Enliven Therapeutics
ELVN
#5643
Rank
NZ$2.06 B
Marketcap
NZ$34.81
Share price
3.49%
Change (1 day)
-15.10%
Change (1 year)

Enliven Therapeutics (ELVN) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$0.66 Million

According to Enliven Therapeutics's latest financial reports the company's total debt is NZ$0.66 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Enliven Therapeutics - Total debt on balance sheet (from 2021 to 2025)

Total debt by year

Year Total debt Change
2024-12-31N/A-100%
2023-12-31NZ$0.52 M4.13%
2022-12-31NZ$0.5 M118.55%
2021-12-31NZ$0.23 M59.96%
2020-12-31NZ$0.14 M